Review: could Erbitux cause White blood cell count decreased?
We study 8,253 people who have side effects while taking Erbitux from FDA and social media. Among them, 194 have White blood cell count decreased. Find out below who they are, when they have White blood cell count decreased and more.
Get connected: join a mobile support group for people who take Erbitux and have White blood cell count decreased >>>
Erbitux (latest outcomes from 8,272 users) has active ingredients of cetuximab. It is often used in cancer.
White blood cell count decreased
White blood cell count decreased (latest reports from 189,247 patients) has been reported by people with hepatitis c, schizophrenia, multiple myeloma, multiple sclerosis, rheumatoid arthritis.
On Oct, 31, 2014: 8,253 people reported to have side effects when taking Erbitux. Among them, 194 people (2.35%) have White Blood Cell Count Decreased.
Time on Erbitux when people have White blood cell count decreased * :
|< 1 month||1 - 6 months||6 - 12 months||1 - 2 years||2 - 5 years||5 - 10 years||10+ years |
|White blood cell count decreased||81.13%||18.87%||0.00%||0.00%||0.00%||0.00%||0.00% |
Gender of people who have White blood cell count decreased when taking Erbitux * :
|White blood cell count decreased||28.08%||71.92% |
Age of people who have White blood cell count decreased when taking Erbitux * :
|White blood cell count decreased||0.00%||1.03%||0.52%||0.00%||0.52%||3.61%||21.13%||73.20% |
Top conditions involved for these people * :
- Non-small cell lung cancer (28 people, 14.43%)
- Head and neck cancer (18 people, 9.28%)
- Rectal cancer (15 people, 7.73%)
- Gastric cancer (14 people, 7.22%)
- Oesophageal adenocarcinoma (13 people, 6.70%)
Top co-used drugs for these people * :
- Cisplatin (89 people, 45.88%)
- Taxol (63 people, 32.47%)
- Carboplatin (52 people, 26.80%)
- Radiation therapy (43 people, 22.16%)
- Decadron (25 people, 12.89%)
* Approximation only. Some reports may have incomplete information.
** Reports from social media are used.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Do you have White Blood Cell Count Decreased while taking Erbitux?
Get connected! Join a mobile support group:
- support group for people who take Erbitux and have White Blood Cell Count Decreased
- support group for people who take Erbitux
- support group for people who have White Blood Cell Count Decreased
Can you answer these questions (Ask a question):
More questions for: Erbitux, White blood cell count decreased
More reviews for: Erbitux, White blood cell count decreased
On eHealthMe, Erbitux (cetuximab) is often used for cancer. Find out below the conditions Erbitux is used for, how effective it is, and any alternative drugs that you can use to treat those same conditions.
What is Erbitux used for and how effective is it:
Other drugs that are used to treat the same conditions:
Drugs in real world that are associated with:
Could your condition cause it?
Related drug studies for: Erbitux, White blood cell count decreased
Recent Erbitux related drug comparison:
More related comparison studies for: Erbitux, White blood cell count decreased
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.